Are localized prostate cancer biomarkers useful in the clinical practice?

Prostate cancer presents itself in a heterogeneous way with both aggressive and indolent forms. Despite the controversy surrounding its use, prostate-specific antigen screening ultimately leads to a greater number of diagnosed patients. One of the biggest challenges in clinical practice is to select...

Descripción completa

Detalles Bibliográficos
Autores principales: Carneiro, Arie, Kayano, Paulo Priante, Gomes Barbosa, Álan Roger, Wroclawski, Marcelo Langer, Ko Chen, Carolina, Cavlini, Giulio Costa, Reche, Guilherme Jose, Sanchez-Salas, Rafael, Tobias-Machado, Marcos, Sowalsky, Adam G, Bianco, Bianca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2018
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602068/
https://www.ncbi.nlm.nih.gov/pubmed/30204063
http://dx.doi.org/10.1177/1010428318799255

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6602068/
https://www.ncbi.nlm.nih.gov/pubmed/30204063
http://dx.doi.org/10.1177/1010428318799255

Ejemplares similares